American Healthcare REIT, Inc. (NYSE:AHR) Position Raised by Zacks Investment Management

Zacks Investment Management raised its position in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 1.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 44,044 shares of the company’s stock after buying an additional 774 shares during the period. Zacks Investment Management’s holdings in American Healthcare REIT were worth $1,252,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Geneos Wealth Management Inc. bought a new stake in shares of American Healthcare REIT in the 4th quarter worth approximately $758,000. Principal Financial Group Inc. increased its holdings in shares of American Healthcare REIT by 54.1% in the third quarter. Principal Financial Group Inc. now owns 9,488,750 shares of the company’s stock valued at $247,654,000 after buying an additional 3,330,714 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of American Healthcare REIT by 76.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,527,123 shares of the company’s stock valued at $65,975,000 after acquiring an additional 1,094,296 shares during the last quarter. Strategic Financial Concepts LLC bought a new stake in shares of American Healthcare REIT during the 4th quarter worth $331,000. Finally, Arkadios Wealth Advisors grew its holdings in shares of American Healthcare REIT by 46.7% in the 4th quarter. Arkadios Wealth Advisors now owns 45,451 shares of the company’s stock worth $1,292,000 after acquiring an additional 14,464 shares during the last quarter. 16.68% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have issued reports on the company. JMP Securities set a $35.00 price objective on American Healthcare REIT in a report on Tuesday, March 4th. KeyCorp cut their price target on shares of American Healthcare REIT from $35.00 to $34.00 and set an “overweight” rating on the stock in a report on Monday, March 31st. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price objective on shares of American Healthcare REIT in a research note on Wednesday, March 19th. Morgan Stanley boosted their target price on shares of American Healthcare REIT from $36.00 to $37.00 and gave the company an “overweight” rating in a research note on Tuesday, March 25th. Finally, Citigroup reaffirmed an “outperform” rating on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Seven research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $33.33.

American Healthcare REIT Trading Up 0.7 %

Shares of NYSE:AHR opened at $30.54 on Friday. The firm has a fifty day moving average of $29.26 and a two-hundred day moving average of $28.05. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. American Healthcare REIT, Inc. has a 12-month low of $13.02 and a 12-month high of $31.61. The firm has a market capitalization of $4.81 billion, a P/E ratio of -63.63, a price-to-earnings-growth ratio of 1.57 and a beta of 1.42.

American Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, April 17th. Shareholders of record on Monday, March 31st were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.27%. The ex-dividend date was Monday, March 31st. American Healthcare REIT’s payout ratio is currently -370.37%.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.